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 1.0 INTRODUCTION 
[1-5] 
             Analytical chemistry, like other areas of chemistry and science, has gone 
through drastic changes and growth. Analytical chemistry may defined as the “Science 
and art of determining the composition of materials in terms of the elements or 
compounds contained”. In analytical chemistry it is of prime importance to gain 
information about the qualitative and quantitative composition of substances and 
chemical species, that is to find out what a substance is composed of and exactly how 
much .                                                                                                                                   
 Analytical method is a specific application of a technique to solve an 
analytical problem. The use of instrumentation is an exciting and fascinating part of 
chemical analysis that interacts with all areas of chemistry and with many other areas 
of pure and applied science. Analytical instrumentation plays an important role in the 
production and evaluation of new products and in the protection of consumers and the 
environment. This instrumentation provides the lower detection limits required to 
assure safe foods, drugs and water. The manufacture of materials, whose composition 
must be known precisely such as substances used in integrated circuit chips, is 
monitored by analytical instruments.          
               Instrumental or physicochemical methods are based on the theory of 
relations between the content and the corresponding physicochemical and physical 
properties of the chemical system being analyzed.  Changes in the system properties 
are either detected or recorded through the measurement of current, electrode 
potential, electrical conductivity, optical density, refractive index etc. with suitable 
and sensitive instruments. In instrumental analysis physical property of substance is 
measured to determine its chemical composition.   
 Measurements of physical properties of analyte such as conductivity, 
electrode potential, light absorption  or emission, mass to charge ratio, and 
fluorescence, began to be used for quantitative analysis of variety of inorganic and 
biochemical analyses. Highly efficient chromatographic and electrophoretic 
techniques began to replace distillation, extraction, and precipitation for the separation 
of components of complex mixtures prior to their qualitative or quantitative 
determination.       
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1.1 PRINCIPAL TYPES OF CHEMICAL INSTRUMENTATION                             
 Spectroscopic Techniques  
1) Ultraviolet & visible Spectrophotometry  
2) Fluorescence & Phosphorescence Spectrophotometry  
3) Atomic Spectrometry (Emission & absorption) 
4) Infrared Spectrophotometry 
5) Raman Spectroscopy 
6) Radiochemical techniques including activation analysis 
7) Nuclear Magnetic Resonance Spectroscopy 
8) Electron Spin Resonance Spectroscopy 
 
 Electrochemical Techniques 
1) Potentiometry  
2) Volta metric techniques 
3) Amperometric techniques  
4) Coulometry 
5) Electrogravimetry  
6) Conductance techniques 
 
 Chromatographic Techniques 
1) High Performance Liquid Chromatography 
2) Gas chromatography 
 
 Miscellaneous Techniques  
1) Thermal analysis 
2) Mass Spectrometry  
3) Kinetic techniques 
 
 Hyphenated Techniques 
1) GC-MS  (Gas Chromatography – Mass Spectrometry) 
2) ICP-MS (Inductively Coupled Plasma - Mass Spectrometry) 
3) GC-IR    (Gas Chromatography – Infrared Spectroscopy) 
4) MS-MS   (Mass Spectrometry – Mass Spectrometry) 
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1.2 INTORDUCTION TO CHROMATOGRAPHY 
[5-7] 
Chromatography was first invented by Michael Tswett, a Russian botanist in 
1906 in Warsaw for the separation of colored substance into individual component.  
Chromatography is defined as a procedure by which solutes are separated 
by a dynamic differential migration process in a system consisting of two or more 
phases, one of which moves continuously in a given direction and in which the 
individual substances exhibit mobilities by reason of differences in adsorption, 
partition, solubility, vapour pressure, molecular size or ionic charge density. The 
individual substances thus obtained can be identified or determined by analytical 
methods.  
Chromatography was invented nearly 100 years ago, but it is only in the past 
few years that the development of the technique and associated instrumentation has 
reached a level that might be called the ‘steady state’. 
Separation Process: 
The Chromatographic method of separation, in general, involves the following steps: 
 Adsorption or retention of substance or substances on the stationary phase. 
 Separation of the adsorbed substances by the mobile phase. 
 Recovery of the separated substances by the continuous flow of the mobile 
phase. 
 Qualitative and quantitative analysis of the eluted substances. 
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 1.2.1   DIFFERENT FORMS OF CHROMATOGRAPHY 
The different forms of chromatography are shown in Fig. 1. 
                                    CHROMATOGRAPHY 
                                                        
 
Gas Chromatography                                      Liquid Chromatography 
                        Gas –Liquid                                                   
                    Chromatography 
        
                         Gas- Solid                                                           
                                   Chromatography  
                                    
                                             
               Adsorption              Partition                Size Exclusion     Affinity            Ion exchange     
 
                             
 
 
Fig 1: Different Forms Of Chromatography 
1.3 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
8 
High performance Liquid Chromatography (HPLC), also known as high 
pressure liquid chromatography, is essentially a form of column Chromatography in 
which the stationary phase consists of small particle (3-50 μm) packing contained in a 
column with a small bore (2-5mm), one end of which is attached to source of 
pressurized liquid eluent  (Mobile phase).           
In High Performance Liquid Chromatography, the mobile as well as the 
stationary phase compete for the distribution of the sample components. In case of 
HPLC, separation is based on: 
 
 Partition      : Separation due to differences in solubility characteristics between 
                         two phases.  
Competition betn 
liquid mobile 
phase and solid 
adsorbent 
Competition bet
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liquid mobile 
phase and liquid 
stationary phase 
 
Molecular 
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Lock & Key 
mechanism 
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 Adsorption     : Separation due to difference in interaction with the surface of the         
                         stationary phase. 
 Ion Exchange: Due to differences in the affinity of ions for the ion exchanger. 
 Size Exclusion: Due to differences in molecular weight and size of the molecules         
                           to be separated.  
Today, HPLC is the most widely used analytical separation method. The 
method is popular because it is non-destructive and may be applied to thermally labile 
compounds (unlike GC); it is also very sensitive technique since it incorporates a wide 
choice of detection methods. With the use of post-column derivatization methods to 
improve selectivity and detection limits, HPLC can easily be extended to trace 
determination of compounds that do not usually provide adequate detector response. 
The wide applicability of HPLC as separation method makes it a valuable separation 
tool in scientific fields. 
1.3.1    MODES OF SEPARATION IN HPLC  
 
There are different modes of separation in HPLC. They are  
 Normal Phase Chromatography (NPC);  
 Reversed Phase Chromatography (RPC);  
 Ion Exchange Chromatography;  
 Ion Pair Chromatography;  
 Size Exclusion Chromatography; and  
 Affinity Chromatography 
 
1.3.2 METHODS USED IN HPLC  
1) Normal phase chromatography  
  For a polar stationary bed like silica we need to choose a relatively non polar 
mobile phase. This mode of operation is termed as Normal phase chromatography. 
Here the least polar component elutes first, and increasing the mobile phase polarity 
leads to decrease in elution time. Isopropanol, diisopropyl ether and acetic acid are 
used as modifiers or tail reducers. Nonpolar solvents like Pentane, Hexane, Iso 
Octane, Cyclohexane, etc. are more popular. It is extremely important to control the 
water content of the stationary phase while using silica columns. Variation in moisture 
content of silica leads to variation in retention times. Therefore, it is a common 
  .                                                                                                                     INTRODUCTION 
 
Arulmigu kalasalingam  college of pharmacy                                                                          6 
 
practice to saturate the mobile phase with water before using it as eluent in Normal 
phase chromatography. It is mainly used for separation nonionic, nonpolar to medium 
polar substances.  
2) Reverse phase chromatography   
   For hydrocarbon type or nonpolar stationary phase, we need to choose a 
polar mobile phase. This mode of partition chromatography is called as Reverse phase 
chromatography. Here the most polar component elutes first. Increasing mobile phase 
polarity leads to decrease in elution time. Common solvents used in this mode include 
Methanol/Acetonitrile/Isopropanol etc. Control of pH is another way to control 
resolution. In the case of an aromatic acid, a low pH buffer will suppress the 
ionization, and will increase the capacity factor, while with a high pH buffer, the 
capacity factor will decrease. Small amounts of modifiers like sodium phosphate/ 
sodium acetate reduce peak tailing, and increase the separation efficiencies. Mostly 
used for separation of ionic and polar substances.  
3) Ion- Pair Chromatography
  
 
  Ion-pair and RP- HPLC have several similar features. The column and mobile 
phase used for both these separation techniques are similar, differing mainly in the 
addition of an ion-pair reagent to the mobile phase for ion-pair chromatography (IPC). 
If RPC method development is unable to provide an adequate separation due to poor 
band spacing, IPC provides selectivity option.   
 1.3.3 Elution Techniques                                                                                       
(a)   Isocratic elution:    
  A separation in which the mobile phase composition remains                
constant throughout the procedure is termed isocratic (meaning constant composition).  
(b)   Gradient elution:                                                                                                      
              The mobile phase composition does not have to remain constant. A 
separation in which the mobile phase composition is changed during the separation 
process is described as a gradient elution. One example is a gradient starting at 10% 
methanol and ending at 90% methanol after 20 minutes. The two components of the 
mobile phase are typically termed "A" and "B"; A is the "weak" solvent which allows 
the solute to elute only slowly, while B is the "strong" solvent which rapidly elutes the 
solutes from the column. Solvent A is often water, while B is an organic solvent 
miscible with water, such as acetonitrile, methanol, THF or isopropanol. 
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   In isocratic elution, peak width increases with retention time linearly 
according to the equation for N, the number of theoretical plates. This leads to the 
disadvantage that late-eluting peaks get very flat and broad. Their shape and width 
may keep them from being recognized as peaks. 
    Gradient elution decreases the retention of the later-eluting components so 
that they elute faster, giving narrower (and taller) peaks for most components. This 
also improves the peak shape for tailed peaks, as the increasing concentration of the 
organic eluent pushes the tailing part of a peak forward. This also increases the peak 
height (the peak looks "sharper"), which is important in trace analysis. The gradient 
program may include sudden "step" increases in the percentage of the organic 
component, or different slopes at different times - all according to the desire for 
optimum separation in minimum time.   
  In isocratic elution, the selectivity does not change if the column dimensions 
(length and inner diameter) change - that is, the peaks elute in the same order. In 
gradient elution, the elution order may change as the dimensions or flow rate change. 
  The driving force is originated in reversed phase chromatography in the high 
order of the water structure. The role of the organic mobile phase is to reduce this high 
order by reducing the retarding strength of the aqueous component. 
1.3.4 HPLC Instrumentation  
  A liquid chromatography consists of a reservoir containing the mobile phase, 
a pump to force the mobile phase through the system at high pressure, an injector to 
introduce the sample into the mobile phase, a chromatographic column, a detector, and 
a data collection device such as a computer, integrator, or recorder. Short, small bore 
columns containing densely packed particles of stationary phase provide for the rapid 
exchange of compounds between the mobile and stationary phases. In addition to 
receiving and reporting detector output, computers are used to control 
chromatographic settings and operations, thus providing for long periods of 
unattended operations.
9-10
 
        The different parts of HPLC system are schematically shown in the Fig.  2. 
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Fig. 2: High Performance Liquid Chromatography (Schematic). 
 
1.4  HPLC METHOD DEVELOPMENT 
1.3.1 METHOD DEVELOPMENT
9-10
 
Today the development of a method of analysis is usually based on prior art or 
existing literature, using the same or quite similar instrumentation. It is rare today that 
an HPLC based method is developed that does not in some way relate or compare to 
existing, literature based approaches. The development of any new or improved 
method usually tailors existing approaches and instrumentation to the current analyte, 
as well as to the final needs or requirements of the method. 
 Method development usually requires selecting the method requirements and 
deciding on what type of instrumentation  to  utilize and why. In the development 
stage, decisions regarding choice of column, mobile phase, detectors, and method of 
quantitation  must be addressed. In this way, development considers all the parameters 
pertaining to any method. 
 
 There are several valid reasons for developing new method of analysis: 
 There may not be suitable method for a particular analyte in the specific sample 
matrix. 
 Existing method may be inaccurate, artifact , and /or contamination prone, or they 
may be unreliable (have poor accuracy or precision) 
 Existing methods may be too expensive, time consuming or energy intensive, or 
they may not be easily automated. 
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 Existing methods may not provide adequate sensitivity or analyte selectivity in 
samples of interest. 
 Newer instrumentation and techniques may have evolved that provide 
opportunities for improved methods, including improved analyte identification or 
detection limits, greater accuracy or precision , or better return on investment. 
 There may be a need for an alternative method to confirm for legal or scientific 
reasons analytical data originally obtained by existing methods. 
Separation Goals And Steps Involved In HPLC Method Development 
    The major steps involved in the methods development are shown in the Fig.  
3 and the separation goals in HPLC method development are shown in Table 1. 
 
Goal Comment 
Resolution  Precise and rugged quantitative analysis requires that Rs 
be greater than 1.5. 
Separation time  <5-10 min is desirable for routine procedures. 
Quantitation  ≤2% (1 SD) for assays; ≤5% for less-demanding analyses; 
≤15% for trace analyses. 
Pressure <150 bar is desirable, <200 bar is usually essential  
(new column assumed). 
Peak height  Narrow peaks are desirable for large signal/ noise ratios. 
Solvent consumption Minimum mobile-phase use per run is desirable. 
 
Table 1: Separation Goals In Hplc Method Development   
 
 
 
 
 
 
 
  .                                                                                                                     INTRODUCTION 
 
Arulmigu kalasalingam  college of pharmacy                                                                          10 
 
               HPLC method development is based on few basic steps includes:
 11-12 
 
 
 
 
 
 
 
  
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
                                      
             Fig 3: Steps in HPLC Method Development 
  
   Once the instrumentation has been selected, based on the criteria suggested 
above, it is important to determine “Analyte Parameters” of interest. To develop a 
method it is necessary to consider the properties of analytes of interest that may be 
advantageous to establish optimal ranges of analyte parameter values. It is important 
that method development may be performed using only analytical standards that have 
1. Information on sample, define 
separation goals 
2. Need for special HPLC procedure, 
sample pre-treatment, etc? 
3. Choose detector and detector setting  
4. Choose LC method; preliminary run, 
estimate best separation conditions 
5. Optimize separation conditions 
6. Check for problems or requirement for 
special procedures 
7a. Recover 
purified 
material 
7c. 
Qualitative 
method 
7b. Quantitative calibration 
8. Validate method for release to routine 
laboratory  
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been well identified and characterized, and whose purity is already known. Such 
precautions will prevent problems in the future and will remove variables when one is 
trying to optimize or improve initial conditions during method development. 
1.3.2 Step-by-Step HPLC method development
13-16 
  
Documentation starts at the very beginning of the method development 
process, a system for full documentation of the development studies must be 
established. All data relating to these studies must be established. All data relating to 
these studies must be recorded in laboratory notebooks or an electronic database.
 
Different steps used in method development are: 
1. Literature collection 
 Search the literature (USP, EP, JP, IP, Chromatography journals, patents, 
internet etc.) for available/ existing HPLC methods for the given molecule or 
molecules having similar structures. 
 Check the suitability of reported literature methods and see if the requirements 
are met. If required, modify the method to meet the requirements such as 
resolution of possible impurities as per the synthetic process. 
 Specify the components to be evaluated in the HPLC method considering all 
the possible impurities that can be present in drug substance which could be 
intermediates, raw materials, process related impurities and degradants. 
 Collect samples, standards and all possible impurities of each stage, if 
available. 
2. Chemical structure and other information 
  Obtain information on analyte solubility, the pKa values (if available) and 
functional groups since it is a prerequisite for effective method development. 
 Based on the structure and the functional group present it can be determined 
whether the compound is basic, acidic or neutral. 
3.  Polarity 
 Depending on the solubility and nature (acid/base/ionic/non-ionic) of the 
molecule select the appropriate mode given below. 
 Reversed phase chromatography - acids, bases and non-ionic sample 
 Ion-pair chromatography - ionic samples. 
 Ion exchange chromatography - ionic samples.  
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 Normal phase chromatography - isomers, non-polar/non-ionic samples, chiral 
molecules. 
 Size exclusion chromatography - high molecular weight samples such as 
proteins. 
4.   pH/pka Value of compounds  
 Based on pH/pKa values, the nature of the compound (acidic, basic or neutral 
in nature) and polarity of the compound can be assumed. 
     Note: if the compound is acidic, acidic mobile phase is preferable. For a basic   
     compound, low pH and basic mobile phase is preferable. For a neutral 
      compound neutral mobile phase is suitable. 
5.  Solubility 
 Check the solubility of the sample in solutions like mobile phase, mobile phase 
organic mixtures, water-organic mixtures and mixtures of acids like perchloric 
acid, phosphoric acid etc. 
Note: If the analyte is soluble in polar solvents like water, methanol, 
chloroform, acetonitrile or tetrahydrofuran, the method development should be 
initiated in reversed phase chromatography. If the analyte is soluble in non-
polar solvents like ethyl acetate, n-hexane, dioxane etc. then the method 
development can be initiated in normal phase chromatography. 
6.  Column selection 
 Reversed phase 
 Column containing C4, C8, C18, Cyano and phenyl, amino stationary 
phases comes under reversed phase category and can be used against a more 
polar mobile phase. The retention of non-polar compounds increases as the 
length of the alkyl ligand (C4, C8, C18 etc.) increases. 
 Normal phase 
Columns containing cyano, phenyl and silica stationary phases come 
under normal phase category and are used against non-polar mobile phases. 
The impact of the bonded phase, internal diameter, particle surface area, pore 
volume and size of theoretical plates, peak symmetry, selectivity and 
resolution should be evaluated. 
 
  .                                                                                                                     INTRODUCTION 
 
Arulmigu kalasalingam  college of pharmacy                                                                          13 
 
7.  Selection of detector 
 Select a suitable detection technique based on the structure and nature of the 
molecule. 
 UV detectors :compounds having chromophores 
 Fluorescence Detector  : Compounds having Fluorescence properties 
 Electrochemical Detector : Easily oxidizable compounds 
 RI Detector: Universal Detector: but cannot be used with gradient elution. This 
detector is used   for compounds which do not contain chromophores.                                          
 ELSD: Universal Detector, but can be used with gradient analysis with higher 
sensitivity.                                                   
8. Mobile phase selection 
  Choice of solvents for reversed phase chromatography 
               The solvents like Water, Methanol, Acetonitrile, Tetrahydrofuran, 
Isopropyl   alcohol, Ethanol etc. 
 Note: when THF is used as mobile phase component, the content should not                  
            be more than 20%. 
  Organic modifiers  
   Triethylamine, Diethyl amine, Trifluoroacetic acid, Phosphates, Perchlorates, 
Chlorides, Bromides, Nitrates etc. 
   Choice of buffering agent  
       Phosphates of sodium, potassium, ammonium etc, perchlorates of 
ammonium, sodium,  potassium etc., ammonium  acetate etc.  Buffering agent 
should be selected appropriately in their buffering range to maintain a constant pH of 
the mobile phase. 
  Choice of solvents for normal phase chromatography 
   Solvents like Isopropyl alcohol, Ethanol, n-hexane, Dioxin, Chloroform etc. 
Organic modifiers used with normal phase chromatography: Triethylamine, Diethyl 
amine, Trifluoroacetic acid, Formic acid and Acetic acid. 
  Ionic compounds 
    Compounds which are highly polar or ionic in nature do not retain on 
reversed phase columns and have poor peak symmetry. For such compounds the 
method should be developed either in ion exchange chromatography mode or ion 
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pair chromatography is preferred because it can be run on the conventional reversed 
phase columns such as C8, C18 etc. with mobile phase additives.  
             Ion pair reagents (sodium lauryl Sulphate, heptane Sulphonic acid, Tetra 
butyl ammonium hydroxide, etc.) of concentrations 0.001%-0.5% can be added to 
the mobile phase to get optimum retention, peak symmetry and separations. 
 Note: Concentrations more than specified range should be justified for acidic 
compounds cationic ion pair reagents like tetra butyl ammonium hydrogen sulphate, 
tetra methyl ammonium bromide, sodium per chlorate, can be used as additives in the 
mobile phase at suitable pH. 
    For basic compounds, anionic ion pair reagents like sodium salt of butane, 
pentane, hexane or octane sulphonic acid, per chlorates etc. can be used as additives in 
the mobile phase at suitable pH. 
9.  Instrument set up and Initial Studies: 
a) Set up the required instrumentation. Verify installation and operational and 
performance qualifications of instrumentation using laboratory standard operating 
procedures (SOP’s). 
b) Always use new consumables (e.g. solvents filters and gases). For example never 
start method development on an HPLC column that has been used before. 
c) Prepare the analyte standard in a suitable injection / introduction solution and in 
known concentration and solvents. It is important to start with an authentic, known 
standards rather than with a complex sample matrix. If the sample is extremely close 
to the standard (eg. Bulk drug), then it is possible to start work with actual sample. 
d) Begin the analysis using the analytical conditions described in the existing 
literature. 
e) Evaluate feasibility of method with regard to the analytical figures of merit obtained 
10) Optimization 
  During optimization change one parameter at a time, and isolate set of 
conditions, rather than use a trial and error approach. . Work from an organized, 
methodical plan, and document every step (Keep a lab notebook) in  case of dead 
ends. 
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11) Demonstration of analytical figures of merit 
              Document the originally determined analytical figures of merit [limit of 
quantitation (LOQ), limit of detection (LOD), linearity, time per analysis, cost, sample 
preparation etc]     
12)  Evaluation of method development with actual samples 
  Ensure that the sample solution leads to unequivocal, absolute identification 
of the analyte peak of interest apart from all other matrix components. 
13) Determination of percent recovery of actual sample and demonstration of 
quantitative sample analysis 
  Determine percent recovery of spiked, authentic standard analyte into sample 
matrix that is shown to contain no analyte. Show   reproducibility of  recovery 
(average ± standard deviation) from sample to sample and whether recovery has been 
optimized. It is not necessary to obtain 100% recovery as long as the results are 
reproducible and known with a high degree of certainty. 
 
1.3.4 Chromatographic Parameters : 
          A) RETENTION TIME 
B) RETANTION VOLUME 
C) SEPERATION FACTOR 
            D) CAPACITY FACTOR 
            E) ASYMMETRIC FACTOR 
            F) THEORETICAL PLATES. 
            G) RESOLUTION 
 
A) RETENTION TIME (Rt): It is the difference in time between the point of 
injection  and the appearance of peak maxima. Retention time is the time required for 
50 % of a component to be eluted from a column. It is measured in minutes or 
seconds. 
B)  RETENTION VOLUME (Vr): It is the volume of carrier gas  required to elute     
50 % of the component from the column.          
               
                                                    R.V=R .T  Flow rate.  
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C) SEPERATION FACTOR:  Separation factor is the ratio of partition - co-efficient 
of the two components to be separated. 
                                                    Kb        Ka               (tb – t o) 
                                                  S =         =               =                         
                                                     Ka        Kb              (ta – t o) 
Where,  to       =    Retention time to unretained substance 
           Kb, Ka =     Partition Coefficient of b and a 
             tb, ta    =     Retention time of substance b and a 
               S       =     depends on liquid phase, column temperature. 
D) CAPACITY FACTOR:  It is generally required to be calculated by the difference 
in the retention time of main peak and the retention time of uracil injected to the 
retention time of the main peak. 
                                             K’  =    Rt-Ru 
                                                           Rt 
Where, Rt : is the retention time of main peak, 
               Ru: is the retention time of uracil. 
               K’:  is the capacity factor  
It is one of the important factor need to be determined while performing method 
development of multi formulation, it should be always less then 2. 
E)  ASSYMETRIC FACTOR: A chromatographic peak should be symmetrical 
about its center and said to follow Gaussian distribution. But due to some factors,  the 
peak is not symmetrical  and shows tailing and fronting.  
 FRONTING: It is  due to the saturation of stationary phase and can be avoided by 
using  less quantity of sample. 
 TAILING: It is due to more active adsorption sites and can be eliminated by 
support pretreatment, more polar mobile phase, increasing the amount of liquid 
phase. 
F)  THEORETICAL PLATES (PLATE THEORY):   A theoretical plate is an 
imaginary or hypothetical unit of a column where distribution of solute between 
stationary and mobile phase has attained equilibrium.   A theoretical plate can also 
be called as a functional unit of the column.    
G) RESOLUTION (Rs) : Resolution  is measure of the extent of separation of the 
two components and the base line separation achieved. 
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1.4 METHOD VALIDATION 
16-18 
 
Validation is defined as follows by different agencies 
  Food and Drug administration (FDA): Establishing documentation 
evidence, which provides a high degree of assurance that specific process, will 
consistently produce a product meeting its predetermined specification and 
quality attributes. 
  World Health Organization (WHO): Action of providing that any 
procedure, process, equipment, material, activity, or system actually leads to the 
expected results. 
  European Committee (EC): Action of providing in accordance with the 
principles of good manufacturing practice, that any procedure, process, 
equipment material, activity or system actually lead to the expected results.  In 
brief validation is a key process for effective Quality Assurance. 
Analytical method validation 
  Analytical monitoring of a pharmaceutical product or of specific 
ingredients within the product is necessary to ensure its safety, efficacy 
throughout all phases of its shelf life.  Such monitoring is in accordance with the 
specifications elaborated during product development.   
  Analytical method validation is the corner stone of process validation 
without a proven measurement system it is impossible to confirm whether the 
manufacturing process has done what it purports to do. All new analytical 
methods developed are validated. 
 Steps followed for validation procedures 
1. Proposed protocols or parameters for validations are established 
2. Experimental studies are conducted 
3. Analytical results are evaluated 
4. Statistical evaluation is carried out 
5. Report is prepared documenting all the results 
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1.4.1 VALIDATION PARAMETERS 
  Analytical methods are required for the identification, batch analysis and 
storage stability data for active constituents of Pharmaceutical product, and for post-
registration compliance purposes. Analytical method development as a first step is 
carried out to ensure that the API used and the dosage forms that are developed and 
manufactured for human consumption are meeting the regulated quality norms. Every 
newly developed method must be validated prior to sample analysis. Validation must 
also be repeated if a parameter has been modified or if the validation was strongly 
performed in another laboratory, to ensure that the methods are transferable. A 
verification is necessary if the analyst or instrument have been changed, or if the 
sample type has been modified. 
  The objective of validation of an analytical method is to demonstrate that the 
procedure, when correctly applied, produces results that are fit for purpose. Method 
validation is a practical process designed and experimentally carried out to ensure that 
an analytical methodology is accurate, specific, reproducible and rugged over the 
specified range of analysis. Validation provides both assurance and reliability during 
normal use and documented evidence that the method is ‘fit for purpose’. 
Method validation ensures the validity of a measurement before it is carried out 
and is essential part of quality assurance procedures. The process of method validation 
provides information on the critical factors affecting the method output, thus enabling  
suitable quality control procedures to be implemented to ensure data quality. The extent of 
method validation will vary with applications, sector and regulatory compliance. 
Typical validation characteristics which should be considered are listed below  
 Accuracy 
 Precision 
 Specificity 
 Detection limit  
 Quantitation limit  
 Linearity 
 Range 
 Robustness etc. 
 Ruggedness 
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1.4.2 ICH VALIDATION PARAMETERS 
19,20
  
 
Table 2 :  Data Elements Required For Validation According To ICH
 
 - signifies that this characteristic is not normally evaluated 
 + signifies that this characteristic is normally evaluated 
 (1) In cases where reproducibility has been performed, intermediate 
precision is not needed 
 (2) Lack of specificity of one analytical procedure could be 
compensated by other supporting analytical procedure(s) 
 (3) May be needed in some cases 
1.5.3 USP VALIDATION PARAMETERS 
19,20
 
      
 
Analytical 
Performance 
Characteristics 
Category I 
Category II
 Category 
III 
Category 
IV Quantitative 
 
Limit 
Tests 
Accuracy Yes Yes * * No 
Precision Yes Yes No Yes No 
Specificity Yes Yes Yes * Yes 
Detection Limit No No Yes * No 
Quantitation 
Limit 
No Yes
 
No
 
*
 
No
 
Linearity Yes
 
Yes
 
No
 
*
 
No
 
Range Yes
 
Yes
 
*
 
*
 
No
 
* May be required, depending on the nature of the specific test. 
                         Table 3: Data Elements Required for Validation According to USP 
Type of analytical 
procedure 
Identification 
Testing  for impurities Assay-dissolution 
(measurement only) 
- content/potency Characteristics Quantitation Limit 
Accuracy - + - + 
Precision 
Repeatability 
Interm. Precision 
 
- 
- 
 
+ 
(1) 
 
- 
- 
+ 
+ 
(1) 
Specificity (2) + + + + 
Detection Limit - (3) + - 
Quantitation Limit - + - - 
Linearity - + - + 
Range - + - + 
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1) Accuracy 
 The accuracy of an analytical method is defined as the degree to which the 
determined value of analyte in a sample corresponds to the true value. Accuracy may 
be measured in different ways and the method should be appropriate to the matrix. 
The accuracy of an analytical method may be determined by any of the following 
ways:  
 Analyzing a sample of known concentration and comparing the measured value 
to the ‘true’ value. However, a well characterized sample (e.g. reference 
standard) must be used.  
  Spiked-placebo (product matrix) recovery method. In the spiked-placebo 
recovery method, a known amount of pure active constituent is added to 
formulation blank (sample that contains all other ingredients except the active 
ingredient), the resulting mixture is assayed, and the results obtained are 
compared with the expected result.  
 Standard addition method. In the standard addition method, a sample is 
assayed, a known amount of pure active constituent is added, and the sample is 
again assayed. The difference between the results of the two assays is 
compared with the expected answer.  
 In both methods (spiked-placebo recovery and standard addition method), 
recovery is defined as the ratio of the observed result to the expected result expressed 
as a percentage. 
 The accuracy of a method may vary across the range of possible assay values 
and therefore must be determined at several different fortification levels. The accuracy 
should cover at least 3 concentrations (50%, 100% and 150%) in the expected range.  
 Accuracy may also be determined by comparing test results with those 
obtained using another validated test method.  
Acceptance criteria: 
  The expected recovery depends on the sample matrix, the sample processing 
procedure and on the analyte concentration. The mean % recovery should be within 
the following ranges: For assay: 98%-102% 
2)  Precision 
The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple sampling 
of the same homogeneous sample under the prescribed conditions. 
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Precision may be considered at three levels:  
 System Precision (Repeatability) 
 Method Precision (Reproducibility) 
 Intermediate precision (Ruggedness) 
The precision of an analytical procedure is usually expressed as the variance, 
standard deviation or coefficient of variation of a series of measurements. A minimum 
of 6 replicate sample determinations should be made together with a simple statistical 
assessment of the results, including the percent relative standard deviation. The 
following levels of precision are recommended.  
Acceptance criteria: For an assay the %RSD should be NMT 2%   
3)  Specificity 
21-23
  
It signifies the instruments, ability to measure or identify the analyte without 
any interference from sample matrix, impurities, precursors or degradation product. 
Forced degradation
 
Forced degradation provides useful information about the degradation 
pathways and degradation products during the product storage. The information thus 
obtained will facilitate pharmaceutical development in areas such as formulation 
development, manufacturing, and packaging, where knowledge of chemical behavior 
can be used to improve the quality of drug product. 
HPLC methods should be able to separate, detect, and quantify the various 
drug-related degradants that can form on storage or manufacturing, plus detect and 
quantify any drug-related impurities that may be introduced during synthesis. Forced 
degradation studies (chemical and physical stress testing) of new chemical entities and 
drug products are essential to help develop and demonstrate the specificity of such 
stability-indicating methods. In addition to demonstrating specificity, forced 
degradation studies can be used to determine the degradation pathways and 
degradation products of the APIs that could form during storage, and facilitate 
formulation development, manufacturing, and packaging. Procedures for the 
preparation of specific degradation products needed for method validation often 
emerge from these studies. 
 For marketing applications, current FDA and ICH guidance recommends 
inclusion of the results, including chromatograms of stressed samples, demonstration 
of the stability indicating nature of the analytical procedures, and the degradation 
pathways of the API in solid state, solution, and drug product. The chemical structures 
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of significant degradation products and the associated procedures for their isolation 
and/or characterization are also expected to be included in the filing. The experimental 
protocol for performing forced degradation studies will depend on the active 
ingredients and formulation involved because the chemistry of each compound is 
different. In general, a target of approximately 10-30% degradation of the API during 
forced degradation, or exposure to energy in slight excess of what is typically used in 
accelerated storage is recommended. In this way, the “worst-case” degradation 
products can be studied. The following will provide some suggestions for performing 
forced degradation studies based upon available guidance from the ICH and FDA. 
Stress testing is likely to be carried out on a single batch of the drug substance. 
The testing should include the effect of temperatures [in 10°C increments (i.e., 50°C, 
60°C) above that for accelerated testing], humidity (i.e., 75% relative humidity or 
greater) where appropriate, oxidation, and photolysis on the drug substance. The 
testing should also evaluate the susceptibility of the drug substance to hydrolysis 
across a wide range of pH values when in solution or suspension.
 
The stress studies should assess the stability of the drug substance in different 
pH solutions, in the presence of oxygen and light, and at elevated temperatures and 
humidity levels. The guidance does not specify pH, temperature ranges, specific 
oxidizing agents, or conditions to use, the number of freeze-thaw cycles, and so on. In 
general, values anywhere between 5% to 20% degradation of the drug substance have 
been considered as reasonable and acceptable for validation of chromatographic 
assays. 
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Different forced degradation conditions to be used for drug substances & products 16 
 
 
 
Fig 4: Different Forced Degradation Conditions To Be Used For Drug Substances & Products 
However, for small pharmaceutical molecules for which acceptable stability 
limits of 90% of label claim is common, pharmaceutical scientists have agreed that 
approximately 10% degradation is optimal for use in analytical validation. In 
designing forced degradation studies, it must be remembered that more strenuous 
conditions than those used for accelerated studies (25°C/60% RH or 40°C/75% RH) 
should be used. 
It must be noted that a forced degradation study is a “living process” and 
should be done along the developmental time line as long as changes in the stability-
indicating methods, manufacturing processes, or formulation changes are ongoing. 
Forced degradation is only considered complete after the manufacturing process is 
finalized, formulations established, and test procedures developed and qualified. 
At a minimum, the following conditions should be investigated:  
1. Acid and base hydrolysis 
2. Hydrolysis at various pH 
3. Thermal degradation 
4. Photolysis degradation 
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4)   Detection limit 
 The detection limit of an analytical procedure is the lowest amount of an 
analyte in a sample that can be detected, but not necessarily quantitated as an exact 
value.  
  The LOD may be determined by the analysis of samples with known 
concentrations of analyte and by establishing the minimum level (lowest calibration 
standard) at which the analyte can be reliably detected. The lowest calibration 
standard which produces a peak response corresponding to the analyte should be 
measured ‘n’ times (normally 6-10). The average response (X) and the standard 
deviation (SD) calculated.  
The LOD = 3.3 * SD/ Slope of Calibration curve 
SD = Standard Deviation  
5) Quantitation limit 
 The limit of quantitation is the lowest amount of the analyte in the sample that 
can be quantitatively determined with defined precision under the stated experimental 
conditions. The limit of quantitation is a parameter of quantitative assays for low 
levels of compounds in sample matrices and is used particularly for the determination 
of impurities and/or degradation products or low levels of active constituent in a 
product. The LOQ may be determined by preparing standard solutions at estimated 
LOQ concentration (based on preliminary studies). The solution should be injected 
and analyzed ‘n’ times (normally 6-10). The average response and the standard 
deviation (SD) of the n results should be calculated and the SD should be less than 
20%. If the SD exceeds 20%, a new standard solution of higher concentration should 
be prepared and the above procedure repeated.  
 The LOQ = 10 * SD/ Slope of Calibration curve 
 SD = Standard Deviation  
6) Linearity 
 The linearity of an analytical method is its ability to elicit test results that are 
directly proportional to the concentration of analytes in samples within a given range 
or proportional by means of well-defined mathematical transformations. Linearity 
may be demonstrated directly on the test substance (by dilution of a standard stock 
solution) and/or by using separate weighing of synthetic mixtures of the test product 
components, using the proposed procedure.  
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Linearity is determined by series injections of whose concentrations span 50-150 
percent of the expected concentration range. The response should be directly 
proportional to the concentrations of the analytes or proportional by means of a well-
defined mathematical calculation. A linear regression equation applied to the results 
should have an intercept not significantly different from zero (0). If a significant 
nonzero intercept is obtained, it should be demonstrated that this has no effect on the 
accuracy of the method.  
7) Range 
The range of an analytical method is the interval between the upper and lower 
levels (including these levels) that have been demonstrated to be determined with 
precision, accuracy and linearity using the method as written. The range is normally 
expressed in the same units as the test results (e.g. percentage, parts per million) 
obtained by the analytical method. 
  For assay tests, the ICH requires the minimum specified range to be 80 to 120 
percent of the test concentration, and for the determination of an impurity, the range to 
extend from the limit of quantitation, or from 50 percent of the specification of each 
impurity, whichever is greater, to 120 percent of the specification. 
8) Robustness 
 Robustness tests examine the effect that operational parameters have on the 
analysis results. For the determination of a method’s robustness, a number of method 
parameters, for example, pH, flow rate, column temperature, injection volume, 
detection wavelength or mobile phase composition, are varied within a realistic range, 
and the quantitative influence of the variables is determined. If the influence of the 
parameter is within a previously specified tolerance, the parameter is said to be within 
the method’s robustness range.  
 Obtaining data on these effects helps to assess whether a method needs to be 
revalidated when one or more parameters are changed, for example, to compensate for 
column performance over time. In the ICH document, it is recommended to consider 
the evaluation of methods robustness during the development phase, and any results 
that are critical for the method should be documented. This is not however, required as 
part of a registration. 
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9) Ruggedness 
 Ruggedness tests examine the effect that operational parameters have on the 
analysis results. The ruggedness was determined by changing the column same   
manufacture but different lot numbers and Analyst variability and system to system 
variability. In all the ruggedness conditions the method parameters shall meet the 
system suitability criteria.  
10) Solution stability  
 Solution stability was determined by Preparing the samples and standard 
solutions at room temperature and inject at initially and after 1 day, 2day, 3day if 
possible Similarly Prepare the mobile phase and keep it at room temperature in well closed 
condition and inject into HPLC system. Evaluate the all the system suitability parameters.  
 
Proposed Acceptance Criteria for the Different Characteristics of Validation by 
ICH 
18 ,20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Table 4: Proposed ICH Acceptance Criteria For The Different Characteristics Of Validation 
 
  
Characteristics Proposed Use Acceptance Criteria 
Linearity r2 ≥ 0.99, similar response ratios 
Precision-System RSD < 2 % 
Precision-Method RSD < 2 % 
Precision 
Repeatability/Reproducibility 
 
RSD ≤ 2 % 
Accuracy FDA 98-102 %, EPA 50-150 % 
Specificity No interference 
Detection Limit >2 times base line 
Quantitative Limit Signal to Noise ratio = 10:1 
Range Concentration where data can be 
reliably detected 
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CHAPTER 3 
REVIEW OF LITERATURE 
 The following methods have been reported for the estimation of Dexketoprofen      
individually and in combination with other drugs. 
1)   M.T.Harde et al 
23 
A simple, fast, accurate and precise method has been developed for the 
simultaneous determination of thiocolchicoside and dexketoprofen from 
pharmaceutical formulation by reversed-phase high performance liquid 
chromatography. The separation was carried out on C18 column using mobile phase 
consisting of a mixture of methanol: phosphate buffer and pH adjusted to 4.5 with 
orthophosphoric acid inthe ratio (65:35 v/v). The flow rate was maintained at 1.0 
ml/min. The UV detection was carried out at a wavelength of 260 nm. The retention 
time for thiocolchicoside and dexketoprofen was found to be 3.02 min and 8.91 min 
respectively. Linear response obtained for thiocolchicoside was in the concentration 
range 4-24 μg/ml (r2 = 0.9998) and dexketoprofen in the range 5-30 μg/ml (r2 = 
0.9990). The relative standard deviation in the tablets was found less than 2% for 
six replicates. The method was validated according to theICH guidelines with 
respect to linearity, precision, accuracy, limit of detection, limit of quantification 
and robustness. Thus, proposed method can be successfully applicable to the 
pharmaceutical preparationcontaining the above mentioned drugs without any 
interference of excipients. 
 
2)   Rao J R et al 24
 
 
 An accurate, simple, sensitive and precise reverse phase high performance liquid 
chromatographic (RP-HPLC) method for the determination of paracetamol and 
dexketoprofen trometamol was developed and validated in the bulk drug and in 
tablet dosage form. Thermo Hypersil ODS–C18 (250 mm × 4.6 mm, 5.0 μ) used as 
stationary phase and methanol: ammonium acetate buffer (65: 35 v/v) as mobile 
phase at a flow rate of 1.0 ml/min and the detection wavelength was 256 nm. The 
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retention time for paracetamol and dexketoprofen trometamol was found to be 3.20 
and 5.94 min, respectively. Proposed method was validated for precision, accuracy, 
linearity range and robustness. 
 
3)    Dhaneshwar et al 
25
  
       In the present study, comprehensive stress testing of Dexketoprofen trometamol 
was carried out according to ICH guideline Q1A (R2). Dexketoprofen trometamol 
is subjected to stress conditions of hydrolysis, oxidation, photolysis and neutral 
decomposition. Additionally, the solid drug is subjected to 50 °C for 60 days in dry-
bath, and to the combined effect of temperature and humidity, with and without 
light, at 40°C/75% RH. The drug was found to degrade significantly in oxidative 
and photo condition whereas it is found to be stable in acidic, alkaline and neutral 
condition. The drug is relatively stable in the solid-state, except formation of minor 
products under accelerated conditions. Successful separation of drug from 
degradation products formed under stress conditions is achieved on a Thermo 
Hypersil BDS–C
18 
(250 mm × 4.6 mm, 5.0 μ) from Germany with isocratic 
conditions and simple mobile phase containing methanol: acetate buffer pH 
adjusted to 4 with glacial acetic acid (65: 35) at flow rate of 1 mL/min using UV 
detection at 255 nm. The method is validated according to ICH guidelines. The 
developed method is found to be precise, accurate, specific and selective.  
 
4)    D. V. Pokharkar et al 26  
A simple, specific, accurate and stability-indicating reversed phase high 
performance liquid chromatographic method was developed for the simultaneous 
determination of Dexketoprofen trometamol and Paracetamol from tablet dosage 
form using a Hypersil BDS, C18 column (5μ, 4.5mm x 250 mm) column and 
mobile phase composed of 0.01m Potassium Dihydrogen Phosphate:acetonitrile 
(75:25 v/v) pH 6.0 adjusted with Triethylamine, at flow rate of ml/min. The 
retention time of Dexketoprofen Trometamol and Paracetamol were found to be 
6.732 and 3.256min respectively. Linearity was established for both drugs in the 
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concentration range of 50-150μg/ml. The percentage recoveries of Dexketoprofen 
Trometamol and Paracetamol were found to be in the range of 98.12%-101.82% 
and 98.15%-101.8% respectively. Detection was carried out at wavelength 254nm 
using photodiode array detector. The separation was carried out at 400
o
C 
temperature. Both the drugs were subjected to acid, alkali, neutral hydrolysis, 
oxidation, dry heat, and UV degradation. The degradation studies indicated 
Dexketoprofen trometamol and Paracetamol showed degradation in acid and alkali. 
The degradation products of Dexketoprofen trometamol and Paracetamol in acidic 
and alkali were well resolved from the pure drug with significant differences in 
their retention time values. This method can be successfully employed for 
simultaneous quantitative analysis of Dexketoprofen trometamol and Paracetamol 
in tablet formulations. 
 
5)   Krunal Pandya et al 27  
The study is focused to developed and validate a UV-Spectroscopic method and 
HPLC Method for simultaneous estimation of Dexketoprofen Trometamol from 
their dosage form. Equation is applied in spectroscopic method, in which 
wavelengths, 260nm has been been selected. At this wavelength drug have 
considerable absorbance. The method was found to be linear in range of 2-12μg/mL 
for Dexketoprofen Trometamol. The accuracy and precision were determined and 
validated statistically.  
A simple Reverse Phase Liquid Chromatographic method has been developed and 
validated for determination of Dexketoprofen Trometamol. The separation was 
carried out using mobile phase consisting of Phosphate buffer: Methanol (30:70). 
The column was used Luna 5u C18 (2) 100A of size 0.25m *4.6mm with flow rate 
of 1.0 mL/min using 260nm as detector. The describe method was linear over 
concentration range of 10-50 ppm for assay of Dexketoprofen Trometamol. The 
retention time of Dexketoprofen Trometamol was found to be 4.31. Result of 
analysis was validated statistically. Both the method shows good reproducibility 
and recovery with less than 1%. All the test above mentioned studies were found to 
be in acceptance criteria. The method was found to be rapid, specific, precise and 
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accurate and can be successfully applied for the routine analysis of Dexketoprofen 
Trometamol bulk and marketed dosage form. 
 
6)    Santosh V.Gandhi et al 28 
This paper describes a simple, sensitive, accurate, and validated reverse-phase high-
performance liquidchromatographic (RP-HPLC) method for the simultaneous 
quantification of these compounds as the bulk drug andin tablet dosage forms. 
Separation was carried out on Jasco HPLC system equipped with HiQ sil C18 HS 
colum(250 × 4.6 mm i.d.) and PDA detector using Methanol: Sodium acetate buffer 
(70:30, v/v) with pH adjusted to 5with Glacial acetic acid as the mobile phase and 
detection was carried out at 265 nm. Results were linear in therange of 5-30 μg 
mL−1 for Dexketoprofen and 1 –10 μg mL−1 for Thiocolchicoside. The method 
was successfully applied for the analysis of drugs in pharmaceutical formulation. 
Results of the analysis were validated statistically and by recovery studies. 
 
7)   Chaudhari et al 29 
Two simple spectrophotometric methods have been developed for simultaneous 
estimation of Thiocolchicoside and Dexketoprofen trometemol from pharmaceutical 
dosage form. Method-I involved simultaneous equation method and Method-II is 
the Q-absorbance method. For simultaneous equationmethod, the absorbances of 
the standard solutions were taken at two wavelengths 368 nm (λ-max of 
Thiocolchicoside) and 258 nm (λ-max of dexketoprofen trometamol). For Q-
absorbance method, the absorbances of the standard solutions were taken at two 
wavelengths 258 nm (λ-max of dexketoprofen trometamol) and 281 nm 
(Isoabsorptive point), in methanol. Linearity range was found to be 2-24 μg/ml for 
dexketoprofen trometamol and Thiocolchicoside in both methods based on the ratio 
of the two drugs in combined dosage form. The accuracy and precision of the 
methods were determined and validated statistically. Both methods showed good 
reproducibility and recovery with RSD less than 2. Proposed methods were found to 
be rapid, specific, precise and accurate and can be successfully applied for the 
routine analysis of dexketoprofen trometamol and Thiocolchicoside in 
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pharmaceutical dosage form        
           
8)   Kadam et al 30
 
The Literature survey indicates several methods for the determination of 
Dexketoprofen trometamol. So an attempt was made to develop and validate a 
simple, precise, accurate, and economical RP-HPLC method as per ICH guidelines 
for the estimation of Dexketoprofen trometamol in bulk and pharmaceutical dosage 
forms. A simple reverse phase HPLC method was developed for the determination 
of Dexketoprofen trometamol present in pharmaceutical dosage forms.C18 (4.6ID x 
250mm) in an gradient mode with mobile phase Acetonitrile: Methanol (25:75) was 
used. The flow rate was 0.9ml/min and effluent was monitored at 262nm. The 
retention time was 2.9 min for Dexketoprofen trometamol. The linearity ranges 
were found to be 30-70μg/ml       
     
9)   Selvadurai Muralidharan et al 31
 
Simple, economic, precise, rugged, sensitive and validated RP-HPLC method has 
been developed to determine dexketoprofen (DKP) tablet. Chromatographic 
separation was achieved isocratically on Thermo, C18column (250mm × 4.6 
mm,5μm and acetonitrile: ammonium acetate buffer (pH 5.0) in the ratio of 400:60 
(v/v) using mobile phase, at a flow rate of 1.0 ml/min. Detection was carried out at 
225 nm. The retention time for DKP was found to be 4.25 min respectively. The 
method was validated as per ICH guidelines. The method was linear in the 
concentration range of 100-600 ng/ml for with correlation coefficient of 0.99 
respectively. The mean recoveries obtained for DKP was 98.14 % respectively. The 
correlation coefficients for all components are close to 1. The present developed 
and validated method was found to be more accurate, precise, selective, rapid and 
easily adapted to bio analytical method. 
 
                                                                                          DRUG PROFILE 
 
Arulmigu kalasalingam college of pharmacy                                                                            32 
 
DRUG PROFILE 21, 22, 23
 
DEXKETOPROFEN : 
Structure   :                                                              
 
 
Chemical name        :    (2S)2 [3(benzoyl) phenyl] propanoic acid 
Description               :    White or almost white crystalline powder. 
Molecular formula   :    C16H14O3 
Molecular weight     :     254.280g/mol 
Melting point            :    94°C (201.2°F) 
Solubility                   :    Freely soluble in water and sparingly soluble in methanol. 
Category                    :    Analgesic 
Half life                      :    1.54±0.63 
 
Pharmacology 
Indication:-  
      Short-term treatment of mild to moderate pain including dysmenorrhoea. 
Pharmacodynamics:- 
                 Dexketoprofen is a propionic acid derivative and an isomeric form of 
ketoprofen. The drug inhibits prostaglandin biosynthesis by inhibition of 
cyclooxygenase pathway (COX-1 and COX-2) 
 
Mechanism of action:- 
 
                 Dexketoprofen belongs to a class of medicines called non-steroidal anti-
inflammatory drugs (NSAIDs).  Prostaglandins are produced in response to injury or 
certain diseases and would otherwise go on to cause swelling, inflammation and pain. 
By blocking cyclo-oxygenase, dexketoprofen prevents the production of 
 prostaglandins and therefore reduces inflammation and pain. Along with Peripheral 
analgesic action it possesses central analgesic action. 
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Absorption:-   
         Dexketoprofen is highly lipophilic.  Absorption is controlled by diffusion 
through membranes. After the adminstrartion absorption is rapid.  
Metabolism:-  
   Deketoprofen is metabolized by liver. The major metabolic pathways involves 
at least two cytochrome p450 enzyme. Dexketoprofen trometamol mostly conjucated to 
an acyl glucronide. 
Route of elimination:- 
   Deketoprofen was eliminated by renal excretion. After completion of 
metabolism unchanged drug found in urine. Elimination is rapid, after repeated 
administration of dosage form no accumulation is found. (25mg Dexketoprofen tablet 3 
times a day). 
Drug interaction:- 
                   Drug interacted with anti coagulants like warfarin, produce gastrointestinal 
bleeding increased hemorrhage, interacted with glycosides possible of increased plasma 
concentration.  
Adverse drug reaction:-  
      Nausea and vomiting, diarrhea, abdominal pain and dyspepsia, common 
gastritis, constipation. Peptic ulcer, gastrointestinal bleeding are rare.           
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AIM  
  To validate the  assay method for  estimat ion o f  Dexketoprofen in 
Dexketoprofen Tablets b y HPLC method, and to demonstrate that the analytical 
procedure is suitable for its intended purpose. 
 
OBJECTIVES 
  On literature survey it was found that Dexketoprofen   was estimated by HPLC 
and UV Spectrophotometric methods, in combination with other drugs in tablet and 
bulk dosage form.  
   And also no method was available for such estimation in the pharmacopoeia. 
In view of the need for a suitable method for routine analysis of Dexketoprofen  in 
formulations, attempts are being made to develop simple, precise and accurate 
analytical methods for estimation of Dexketoprofen and extend it for their 
determination in formulations.  
The utility of the developed methods to determine the content of drug in commercial 
tablet is also demonstrated. Validation of the method was done in accordance with USP 
and ICH guidelines for the assay of active ingredients. The methods were validated for 
parameters like accuracy, linearity, precision, specificity, ruggedness, robustness, and 
system suitability. This proposed method was suitable for the pharmaceutical analysis 
in analytical laboratories. 
 
          This method validation protocol provides a high degree of assurance that a 
specific process will consistently produce that the DEXKETOPROFEN TABLETS 
25 mg meeting its predetermined specification, quality characteristics, and to validate 
the HPLC method using the working standard, Placebo and drug product. 
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METHOD DEVELOPMENT 
MATERIAL AND INSTRUMENTS 
CHEMICALS 
Table No. 5: Material and Chemicals 
Instruments: 
  A. Spectrophotometer Double beam UV visible spectrophotometer    
                             with 10mm matched quartz cells 
Model                  UV 1700 
Make                   Shimadzu 
B. HPLC                         Gradient System 
Pump                   Agilent 1260 & 1290  series 
Detector              Variable Wavelength Detector  
Software              Chemstation 
Column               Agilent Zorbex C18,  (250×4.6 mm 5µ) 
C. Analytical Balance     Metler Toledo XS105 
D. P
H
 Meter                    Susima Digital pH meter 
E. Sonicator                    PCI  India  Ultrasonic Bath Sonicator 
F. Filter                           Nylon & PVDF 0.45µm (Millipore) 
 
All the glassware’s used were of borosilicate glass of class A and all the solvents
 and prepared solutions were filtered through Nylon filter 0.45u. 
 
 
Table No. 6 : Details of Marketed formulation 
 
Sr. No Chemical/ Solvent Make Grade 
1 Potssium dihydrogen 
orthophosphate 
Merck AR 
2 Acetonitrile Spectrochem AR 
3 O- phosphoric acid Fisher scientific AR 
4 HPLC  water  - - 
  Drug Dexketoprofen 
 
Label claim 
 
Dexketoprofen 25 mg 
 
Manufactured by Caplin point Laboratories, India 
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Table no. 7: Details of Procured Drugs  
5.2 Study of spectra and selection of wavelength: 
 
Selection of solvent:  
 
        Solubility of the drug was checked in solvent like water, methanol, acetone, 
acetonitrile, dimethylsulphoxide, dimethylforma-mide, dimethyl amine etc. and 
solubility of dexketoprofen enhanced in Methanol and water that wise it selected as 
diluent. 
Preparation of Diluent: 
Methanol: Water-(60:40) v/v. 
 
Dexketoprofen Trometamol standard solution: 
An accurately weighed 73.9 mg of Dexketoprofen Trometamol (equivalent to 50mg of 
deketoprofen) was taken in 250 ml Volumetric flask dissolved and volume was made to 
mark with diluent.  (Concentration of Dexketoprofen  200µg/ml) 
The standard solution made further concentration as follows 60µg, 80µg, 100µg, 120 
µg, 140µg, these solutions were scanned in the range of 400 to 200 nm in the 1cm cell 
against blank. The UV absorbance spectrum of Dexketoprofen is shown in Fig.No: 5 
 
 Fig no. 5:  Stacked graph of Dexketoprofen  
Drug Procured from Assay result Used as 
Dexketoprofen 
Trometamol  
Caplin point Laboratories, 
India 
 
99.20% 
 
Standard 
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                               Table no: 08  Absorbance of uv spectrum in various concentrations 
 
 
 
 
 
 
                    
                        
Concentration Absorbance 
Blank 0.000 
6mcg 0.255 
8mcg 0.359 
10mcg 0.421 
12mcg 0.512 
16mcg                     0.689 
 
                                                  Fig. No. 6 : Linearity  of  Dexketoprofen 
 
Dexketoprofen  obeys Beers law in the range of 0- 160mcg concentrations and 
shows the 
      R
2
 = 0.998. At 260 nm shows good linearity, Hence this wavelength selected 
for estimation. 
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Estimation of Dexketoprofen in Tablet Formulation Form by RP-HPLC 
Selection of Mobile Phase 
Based on sample solubility, stability and suitability, various mobile phase compositions 
were tried to get a good resolution and sharp peak. 
The standard solution of Dexketoprofen Trometamol was run in different mobil phase. 
Higher solublitiy of dexketoprofen in water,that wise in mobile phase water  used half of 
amount in preparation of mobile phase. 
  
The following mobile phases were used: 
1) Buffer : Methanol:Water [1:52:48] 
2) Buffer : Methanol: Water [5:45:50] 
3) Buffer : Methanol: Water [2:48:50] 
 
Preparation of Reagent: 
 
Buffer solution :  
Weigh accurately about 6.8 g of Potassium dihydrogen orthophosphate and transfer 
into a 100 mL volumetric flask. Add about 60 mL of purified water to dissolve and 
dilute up to the volume with water. Adjust the pH  to 3.50 ± 0.05 with 
Orthophosphoric acid. 
Given above ratio of mobile phase were prepared. Buffer, Methanol, Water mixed             
well and it degassed, then it filtered through the 0.45 filter.   
 
 
TRIAL - 1 
Chromatographic conditions:- 
 
 
 
 
 
 
 
                                 Table No. 09:  Chromatographic condition of trial -1 
Parameter/ 
Conditions 
Description/Values 
Column name   C18 (250*4.6) mm, 5µ 
Detector VW Detector 
Flow rate 1.5 ml/min 
Injection volume 20µl 
Wavelength 260 nm 
Column Temp. Ambient 
Buffer Phossphate  buffer pH 3.5 
Mobile phase Buffer : Methanol:Water (1:52:48) 
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                           Fig. No. 07 : Chromatogram of trial-1 
 
 
Observation:- 
 
 
 
 
 
 
Conclusion:- 
USP Plate count of Dexketoprofen  is  also  below the limit. and the retention time of       
Dexketoprofen is 3 mins.hence it’s  run in very short run time.so next trial was  
proposed. 
In this method mobile phase’s organic solvent ratio is increased,that wise the RT of  the 
dexketoprofen is less efficient,the next trail method, solvent ratio decreased and buffer 
ratio were increased. 
 
 
 
 
 
Peak Name RT 
USP 
Tailing 
USP Plate 
Count 
Dexketoprofen 3.221 0.500 2970 
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Trial - 2 
Chromatographic conditions:- 
 
 
     
 
 
 
                                     Table no. 10:  Chromatographic condition of trial -2 
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                               Fig. No. 08 : Chromatogram of trial-2 
 
Observation:- 
 
 
 
 
 
Observation:- 
In this trail ratio of buffer increased for increase the retention time of the    
dexketoprofen, but this trail was showed increased retention time. And run time also 20   
minutes, so this trail method was rejected. Next trail method were proposed 
Parameter/ 
Conditions 
Description/Values 
Column name   C18 (250*4.6) mm, 5µ 
Detector VW Detector 
Flow rate 1.5 ml/min 
Injection volume 20µl 
Wavelength 260 nm 
Column Temp. Ambient 
Buffer Phossphate  buffer pH 3.5 
Mobile phase Buffer : Methanol:Water (5:45:50) 
Peak Name RT 
USP 
Tailing 
USP Plate 
Count 
Dexketoprofen 12.423 0.37 3532 
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Trial - 3 
Chromatographic conditions: 
 
 
 
 
 
 
                       Table no. 11: Chromatographic condition of trial -3 
 
 
 
 
 
 
 
 
                                              Fig. No. 09 : Chromatogram of trial-3 
Observation:- 
                        
 
 
 
Conclusion:   
Tailing factor was <2.0, Plate count was >2000, run time is 10 minutes only, 
RT was 4mins,   so this method is considered as the optimized method. 
 
Parameter/ 
Conditions 
Description/Values 
Column name   C18 (250*4.6) mm, 5µ 
Detector VW Detector 
Flow rate 1.5 ml/min 
Injection volume 20µl 
Wavelength 260 nm 
Column Temp. Ambient 
Buffer Phossphate  buffer pH 3.5 
Mobile phase Buffer : Methanol:Water (2:48:50) 
Peak Name RT 
USP 
Tailing 
USP Plate 
Count 
Dexketoprofen 4.333 1.47 3998 
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METHOD VALIDATION 
Preparation of Buffer Solution: 
Mobile Phase-A:-   Weighed accurately 6.8 g of Potassium dihydrogen orthophosphate and 
transferred into 100 mL volumetric flask. Added 60 mL of purified water. Dissolved and 
diluted up to the volume with water. Adjusted the  pH  to 3.50 ± 0.05 with Orthophosphoric 
acid. 
Preparation of Mobile Phase: 
Mobile Phase: Prepared a mixture 20 volume of buffer, 480 volume of Acetonitrile, and 500 
volume of water, mixed and sonication was done for 10 minutes and filtered the solution 
through 0.45 µm nylon filter. 
Preparation of Diluents: Mobile Phase  
Preparation of Standard Solution: (250 mcg/mL of Dexketoprofen) 
Weighed accurately 92.3 mg of Dexketoprofen Trometamol WS (Equivalent to 62.5 mg of 
Dexketoprofen) and transferred into 100 mL volumetric flask. Added 60 mL of diluent and 
sonication was done for 5 minutes. Dissolved and diluted up to the volume with diluent. 
Pipette out 10 mL of the above solution and transferred into 25 mL volumetric flask and 
diluted up to the volume with diluent. Filtered the solution through 0.45 µm nylon filter and 
collected the solution in an HPLC vial after discarded the first 2 mL of filtrate.   
Preparation of Sample Solution: (250 mcg/mL of Dexketoprofen)   
Weighed and finely powdered not fewer than 10 tablets. Transferred accurately weighed 
portion of the powder equivalent to 125 mg of Dexketoprofen into 100 mL volumetric flask. 
Added 60 mL of diluent and sonication was done for 15 minutes. Dissolved, cooled and 
diluted up to the volume with diluent. Pipette out 5.0 mL of the above solution and transferred 
into 25 mL volumetric flask and diluted up to the volume with diluent. Filtered the solution 
through 0.45 µm nylon filter and collected the solution in an HPLC vial after discarded the 
first 2 mL of filtrate. 
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Chromatographic conditions: 
 
Parameter/ 
conditions 
Description/Values 
 
Column name Agilent Zorbax SB C18 (250*4.6) mm,5µm 
Flow rate 1.5 ml/min 
Injection volume 20 µl  
Wavelength 260 nm 
Column Temp. Ambient 
Run time 10 min 
Buffer  3.50 pH 
Mobile phase  Isocratic 
 
Table No. 12:  Chromatographic condition of Optimized method 
 
 
                                      Fig. No. 10  : Chromatogram of Blank 
 
 
 
 
           
Fig, No. 11  : Chromatogram of Standard 
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Observation:  
Name 
RT 
(min) 
Area 
(µv
*
sec) 
USP 
Plate 
Count 
USP 
Tailing 
Dexketoprofen 4.333 657221971 3918 1.49 
 
  
Fig. No. 12  : Chromatogram of Sample 
 
Name 
RT 
(min) 
Area 
(µv
*
sec) 
USP 
Plate 
Count 
USP 
Tailing 
Dexketoprofen 4.840 657921232 4204 1.48 
 
 
 
Calculations: 
 
         Content of Dexketoprofen in  mg :  
   SPL Area     STD wt          10          100              25      STD Purity in ASB   254.28 
=  --------------x----------------x-------x-------------x---------x-------------------x------------ x Avg. wt 
   STD Area        100             25     Wt. of SPL       5              100                  375.42 
  
= 254.28 is a molecular weight of Dexketoprofen.  
= 375.42 is a molecular weight of Dexketoprofen Trometamol.  
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Content of Dexketoprofen in  % : 
              Dexketoprofen in mg 
= ---------------------------------------------- x 100 
   The Label claim of each Tablet (in mg) 
 
Acceptance Criteria: 
22.50 mg to 27.50 mg (90.00 % to 110.00 % of label claim) 
Laoratory 
Mixtures 
 
Area Obtained 
 
Amount in 
mg 
Percentage of 
Drug 
Standard 657221971 26.24 104.96 
Sample 657921232 26.10 104.40 
    
Table No. 13:  Results for Assay 
 
i) System Suitability 
Standard solution was prepared as per the proposed test method and injected into the 
HPLC system in six replicates and chromatograms were recorded. The system is 
suitable for analysis if 
 The USP plate count of Dexketoprofen peak should not be less than 2000. 
 
 The USP tailing for  peak should not be more than 2.0  
 The % RSD of peak area response for six replicate injections for Dexketoprofen 
peak  not more than 2.0 %.      
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suitability  
ig. No. 13  : Chromatograms for standard solution for system suitability 
 
 
 
 
 
 
 
 
Fig No. 13:Chromatogram for standard solution for system suitability 
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System suitability results for Dexketoprofen 
                                    
 
 
 
 
 
Table No. 14:  System suitability results for Dexketoprofen 
Observation: 
It was observed from the data tabulated above that all the system suitability parameters 
meet the predetermined acceptance criteria as per the test method and indicates the 
suitability of the selected system.  
ii) Linearity and Range                                                                              
The linearity of an analytical method is its ability to elicit test results that are directly, 
or by a well-defined mathematical transformation, proportional to the concentration of 
analyte in samples within a given range. A series of standard concentrations were 
prepared from 10% to 200% of the targeted concentration of Dexketoprofen. A linearity 
graph of concentration (μg/ml) versus average area response was plotted for 
Dexketoprofen peak and the correlation coefficient was calculated.       
Preparation of Stock Solution: Accurately weighed and transferred about 92.31 mg of 
Dexketoprofen Trometamol working standard (Equivalent to 62.5 mg of 
Dexketoprofen) into a 50 ml volumetric flask. Add about 25 mL of diluent and sonicate 
for 10 minutes, to dissolve and dilute up to the volume with diluent.  
                                                  ( Concentration of Dexketoprofen is about 1250µg/ml)  
 
Name Inj RT (min) Area (µv*sec) USP Plate Count USP Tailing 
Dexketoprofen 1 5.70 634290937 5051 1.56 
Dexketoprofen 2 5.70 634874613 5070 1.54 
Dexketoprofen 3 5.71 635331197 5090 1.50 
Dexketoprofen 4 5.70 635404281 5073 1.53 
Dexketoprofen 5 5.70 635194094 5087 1.54 
Dexketoprofen 6 5.70 635491917 5074 1.55 
Mean 635097840 5074 1.54 
Std Dev. 450299.0 
% RSD 0.071 
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Preparation of Linearity Dilutions for Dexketoprofen.  
Linearity Dilutions 
Linearity 
Level 
(%) 
Volume of 
Stock Taken 
(ml) 
Diluted to 
(ml) 
Final Conc. 
(μg/ml) 
Dexketoprofen 
10 1 50 25 
20 1.0 25 50 
50 5.0 25 125 
100 5.0 25 250 
120 6.0 25 300 
160 8.0 25 400 
200 10.0 25 500 
                                  Table No. 15:  Linearity Dilutions 
 
oo 
 
 
 
 
Fig. No. 25: Chromatograms for Linearity at 10% 
 
 
 
 
                                            Fig. No. 14  : Chromatograms for Linearity at 20% 
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                                         Fig. No.15: Chromatograms for Linearity at 50% 
555555555550\\\\\\\\\  
Fig. No. 16  : Chromatograms for Linearity at 100% 
  
                                     Fig. No. 17 : Chromatograms for Linearity at 120% 
 
Fig. No. 18  : Chromatograms for Linearity at 160% 
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                              Fig. No.19  : Chromatograms for Linearity at 200%  
REPORT: 
The linearity response of Dexketoprofen was determined across the range are given in 
the following tables. The result shown in the table and its graphical representation 
indicates that the response is linear over the specified range 
 
Linearity data obtained from 10 % to 200 % for Standard: 
 
                                             Table No.16 :  Linearity Data 
Linearity 
level 
concentration 
in % 
Concentration of  
Dexketoprofen 
(µg/mL) 
Sample area -1 Sample area-2 
Average 
area 
10 25 68651042 68762225 68706634 
20 50 134684907 135044793 134864850 
50 125 356488901 357047686 356768294 
100 250 663177879 663185028 663181454 
120 300 783888776 784329728 784109252 
160 400 1064539197 1062691472 1063615335 
200 500 1333597687 1334595109 1334096398 
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                                                          Table No.17: System suitability Data  
                      
Linearity graph obtained for Standard: 
 
                                          Fig. No. 20 : Graph for Linearity standard 
Correlatione co efficient: 0.99947 
Slope: 2642333.343 
Intercept: 6498885.981 
 
 
S.No Parameter 
Results 
obtained 
Acceptance 
criteria 
01. Tailing factor for Dexketoprofen 1.48 NMT 2.0 
02. %RSD of Dexketoprofen area for 
six standard injections 
0.16 NMT   
2.0% 
03. Theoretical Plates for the peak due 
to Dexketoprofen 
3774 NLT 2000 
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Sample Stock solution (625 mcg/mL of Dexketoprofen): 
Weigh and finely powder not fewer than 10 tablets. Transfer accurately weigh portion 
of the powder equivalent to 125 mg of Dexketoprofen into a  50 mL volumetric flask. 
Add about 30 mL of diluent and sonicate for 15 minutes to dissolve. Cool and dilute 
up to the volume with diluent.  
Linearity Dilutions 
Linearity 
Level 
(%) 
Volume of 
Stock Taken 
(ml) 
Diluted to 
(ml) 
Final Conc. 
(μg/ml) 
Dexketoprofen 
10 1 50 25 
20 1.0 25 50 
50 5.0 25 125 
100 5.0 25 250 
120 6.0 25 300 
160 8.0 25 400 
200 10.0 25 500 
                                    Table No. 18:  Linearity Dilutions 
 
  
 
 
 
                               Fig. No.  : Chromatograms for Linearity at 10% 
 
                                      Fig. No.21  : Chromatograms for Linearity at 20% 
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Fig. No.22  : Chromatograms for Linearity at 50% 
 
 Fig. No.23  : Chromatograms for Linearity at 100% 
 
 
 Fig. No.24  : Chromatograms for Linearity at 120% 
 
 
 
 
                                   Fig. No.  : Chromatograms for Linearity at 160% 
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                                   Fig. No.25  : Chromatograms for Linearity at 200% 
 
REPORT: 
The linearity response of Dexketoprofen was determined across the range are given in 
the following tables. The result shown in the below table and its graphical 
representation indicates that the response is linear over the specified range 
Linearity data obtained from 10 % to 200 % for Standard 
                         
                                  Table No. 19:   Linearity  of  Dexketoprofen 
Linearity level 
concentration in 
% 
Concentration of  
Dexketoprofen 
(µg/mL) 
Sample area -1 Sample area 
Average 
area 
10 25 72167886 72386578 72277232 
20 50 143070269 142038911 142554590 
50 125 350084739 350540979 350312859 
100 250 687987277 687142472 687564875 
120 300 808364399 808727071 808545735 
160 400 1096605577 1099591338 1098098458 
200 500 1391525072 1391837116 1391681094 
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                                   Fig. No. 26  : Linearity Plot of  Dexketoprofen 
Correlatione co efficient: 0.99947 
Slope: 2642333.343 
Intercept: 6498885.981 
 
Data Interpretation 
The Correlation coefficient for Dexketoprofen was found to be 0.9995, which indicates 
that the peak responses are linear. This concluded that the method was linear 
throughout the range selected. 
 
iii) Precision 
The precision of an analytical method is the degree of agreement among individual test 
results when the method is applied repeatedly to multiple sampling of homogeneous 
sample. The precision of analytical method is usually expressed as the standard 
deviation or relative standard deviation (coefficient of variation) of series of 
measurement. 
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System precision 
Standard solution was prepared as per the proposed test method for system precision 
studies. Six replicate injections were injected into the HPLC system. The % RSD for 
the peak responses of six replicate injections should be NMT 2.0. 
Theoretical plates of the peak obtained for six replicates standard solution injections of 
Dexketoprofen should be not less than 2000. 
The tailing factor of the peak due to Dexketoprofen from six replicates standard solution 
injections should be not more than 2.0. 
 
 
 
 
 
 
 
                                 Fig. No. 27  : Chromatograms for system Precision 
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                                        Peak Results for System Precision 
Inj. RT (min) Area (μV*sec) Tailing 
Factor 
Theoretical 
Plates 
1 5.70 634290937 1.56 5051 
2 5.70 634874613 1.54 5070 
3 5.71 635331197 1.50 5090 
4 5.70 635404281 1.53 5073 
5 5.70 635194094 1.54 5087 
6 5.70 635491917 1.55 5074 
Mean 635097840 1.54 5074 
% RSD 0.071 
Table No. 20 :  Peak Results for System Precision 
Data Interpretation 
It is observed from the data tabulated above, that the % RSD of the peak responses as 
peak area was found to be within acceptance criteria indicating an acceptance level of 
precision for system precision studies. 
Method Precision                                                                                                                    
In method precision, a homogenous sample of a single batch should be analysed six 
times. This indicates whether a method is giving consistent results for a single batch. 
The % RSD for the six determinations should be NMT 2.0 
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                            Fig. No. 28 : Chromatograms for Method Precision 
 
Method Precision Results for Dexketoprofen  
No. of 
Sample     
Samples Area Results obtained 
Sample -1 Sample -2 Average 
Amount of drug 
present  
in mg 
 Percentage  
of drug  
01 698152127 698926730 698539429 25.94 103.76 
02 692342080 692477262 692409671 25.93 103.72 
03 685167327 686704800 685936064 26.21 104.84 
04 699465361 698867877 699166619 26.07 104.28 
05 691698691 692857520 692278106 26.23 104.92 
06 686455597 686143821 686299709 26.12 104.48 
 
Mean 104.33 
Std. Dev 0.52 
RSD 0.494 
 
                                Table No. 21:  Method Precision Results for Dexketoprofen  
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Data Interpretation 
From the above results, it was concluded that the method is precise. 
iv)Accuracy: 
The accuracy of an analytical method is the closeness of test results obtained by that 
method to the true value. The accuracy study was conducted by spiking the known 
amount of active ingredients into the placebo at three different levels (80%, 100% and 
120% of target concentration). The samples were analysed as per the proposed test 
procedure and the % recovery for each spiked level was calculated. The % RSD at 
each spike level should be NMT 2.0. The overall % RSD for % recovery for all spike 
level should be NMT 2.0. The % recovery at each spike level should be NLT 98.0 and 
NMT 102.0 of the added amount. 
Procedure for accuracy 
Accuracy at 80%: 
 Accurately weighed 2025 mg of placebo, 147.68 mg of Dexketoprofen trometamol 
(Equivalent to 50.0 mg of Dexketoprofen) was transferred to 50 ml volumetric flask. To 
it 30 ml of diluent was added and sonicated for 15 minutes with occasional shaking, 
cooled at room temperature and diluted to volume with diluent. Further 5 ml is diluted 
to 25 ml with diluent. 
Accuracy at 100%: 
 Accurately weighed 2025 mg of placebo, 184.60 mg of Dexketoprofen Trometamol 
(Equivalent to 62.5 mg of Dexketoprofen) was transferred to 50 ml volumetric flask. To 
it 30 ml of diluent was added and sonicated for 15 minutes with occasional shaking, 
cooled at room temperature and diluted to volume with diluent. Further 5 ml is diluted 
to 25 ml with diluent. 
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Accuracy at 120%:  
Accurately weighed 2025 mg of placebo, 221.5 mg of Dexketoprofen Trometamol 
(Equivalent to 75.0 mg of Dexketoprofen) was transferred to 50 ml volumetric flask To 
it 50 ml of diluents  was added and sonicated for 30 minutes with occasional shaking, 
cooled at room temperature and diluted to volume with diluent. Further 5 ml is diluted 
to 25 ml with diluent. 
 
Fig. No. 29 : Chromatograms for Accuracy at 80% level 
         
                                      Fig. No.30: Chromatograms for Accuracy at 100% level 
 
 
 
 
                    Fig. No. 40  : Chromatograms f 
                                      Fig. No. 31: Chromatograms for Accuracy at 120% level 
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 Peak Results for Accuracy of Dexketoprofen 
      
                        Table No. 22:   Peak Results for Accuracy of Dexketoprofen 
                                   
                                               Table No.23: System suitability Data 
 
 
Accuracy 
Level in % 
Dexketoprofen 
added in mg 
Dexketoprofen 
recovered in mg 
% Recovered 
Mean of % 
Recovered  
80 
0.29774 0.29804 100.10 
100.60 
0.29738 0.30031 100.98 
100 
0.37216 0.37583 100.47 
100.25 
0.37022 0.37339 100.56 
120 
0.44464 0.44708 99.70 
99.55 
0.44498 0.44305 99.32 
S.No. Parameter 
Results 
obtained 
Acceptance criteria 
01 Tailing factor for Dexketoprofen 1.49 NMT 2.0 
02 
%RSD of Dexketoprofen  area 
for six standard injections 
0.371 
NMT 2.0% 
03 
Theoretical Plates for the peak 
due to Dexketoprofen 
3968 NLT 2000 
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Data Interpretation                                                                                                           
             On the basis of these chromatograms we can say that there is no interference of 
blank and placebo at the retention time of Dexketoprofen . Hence the method is 
specific. 
v) Specificity 
Blank & Placebo Interference: Placebo was injected in triplicate by weighing the 
equivalent amount present in the finished drug product and analysed for interference 
due to placebo. 
 
                                           Fig. No. 32 : Chromatogram of Blank (Diluent) 
       
 
 
                           
                                        Fig. No. 33 : Chromatogram of Placebo 
Data Interpretation                                                                                                           
On the basis of these chromatograms we can say that there is no interference of blank 
and placebo at the retention time of Dexkeoprofen .Hence the method is specific. 
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VI ) INTERMEDIATE PRECISION-(RUGGEDNESS): 
Intermediate precision expresses within-laboratories variations: different days, different 
analysts, different equipment, etc. 
     Intermediate precision is to be performed by different analyst coupled with different day.  
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                                 Fig. No.34 : Chromatogram of Intermediate-Precision 
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Intermediate Precision Results for Dexketoprofen 
No. of 
Sample    
Samples Area Results obtained 
Sample -1 Sample -2 Average 
Amount of drug 
present  
in mg 
 Percentage  
of drug  
01 657221971 657921232 657571602 26.24 104.96 
02 671649864 672807248 672228556 26.10 104.40 
03 671898722 672457317 672178020 26.22 104.88 
04 666650867 667691114 667170991 26.08 104.32 
05 670589937 672271795 671430866 26.13 104.52 
06 672701057 673997960 673349509 26.09 104.36 
 
Mean 104.57 
Std. Dev 0.28 
RSD 0.266 
                    Table No.24:   Peak  Results for  intermediate Precision of  Dexketoprofen 
                                             Table No.25: System suitability Data 
 
S.No. Parameter 
Results 
obtained 
Acceptance criteria 
01 Tailing factor for Dexketoprofen 1.58 NMT 2.0 
02 
%RSD of Dexketoprofen area 
for six standard injections 
0.146 
NMT 2.0% 
03 
Theoretical Plates for the peak 
due to Dexketoprofen 
4893 NLT 2000 
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 REPORT: 
System suitability result passes and the results obtained for Intermediate precision are found 
within the acceptance criteria. Hence, it is concluded that the assay method is capable to 
generate, repeatable assay results for Dexketoprofen tablets in multiple preparations of a 
unique batch, besides by a different analyst. 
 
VII ) ROBUSTNESS: 
The Robustness for the analytical procedure expresses a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides an indication 
of its reliability during analysis. 
Change in flow rate plus (1.7 ml/minute): 
For Chromatographic conditions, follow the method of analysis same, except changing the flow 
to 1.7 ml / minute instead of 1.5 ml / minute. 
Change in flow rate minus (1.3 ml/minute): 
For Chromatographic conditions, follow the method of analysis same, except by changing the 
flow to 1.3 ml / minute instead of 1.5 ml / minute. 
Change in wavelength plus (262 nm): 
For Chromatographic conditions, follow the method of analysis same, except by changing the 
wavelength to 262 nm instead of 260 nm. 
Change in wavelength minus (258nm): 
For Chromatographic conditions, follow the method of analysis same, except by  
changing the wavelength to 258 nm instead of 260 nm. 
Change in mobile phase organic content plus (+ 5 %): 
Change the least Buffer ratio to 21 instead of 20, and adjust the quantity  variation         
from Acetonitrile concentration to maintain 100%. Maintain other chromatographic 
condition remains same. 
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Change in mobile phase organic content minus (- 5 %): 
Change the least Buffer ratio to 19 instead of 20, and adjust the quantity variation from 
Acetonitrile concentration to maintain 100%. Maintain other chromatographic 
condition remains same.  
 
   Fig. No. 35 : Chromatogram of Flow rate Minus 
 
                                                 Fig. No. 36 : Chromatogram of Flow rate  Plus 
 
 
 
 
                                              Fig. No. 37 : Chromatogram of  Wavelength Minus 
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Fig. No. 38 : Chromatogram of  Wavelength Plus 
         
                                                    
                                                                       
                                       Fig. N 
 
                                   Fig. No. 39 : Chromatogram of  Mobile Phase Minus       
                                 
                                                
                                
                                       
  
                                                Fig. No. 40 : Chromatogram of  Mobile Phase Plus 
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                                             Table No.26 System suitability Data 
                               Table No.27:   Peak  Results for  Robustness of  Dexketoprofen 
 
S.No. Parameter Name 
Dexketoprofen Results obtained 
Tailing factor  Area (RSD) 
Theoretical 
Plates 
01 
 Wavelength 262 nm 
minus 
1.46 0.17 4464 
02  Wavelength 258 nm 1.45 0.26 4458 
03  Flow rate 1.3 mL 1.50 0.20 4420 
04  Flow rate 1.7 mL 1.43 0.19 4068 
05  Mobile phase  plus 1.51 0.03 4509 
06  Mobile phase minus 1.49 0.11 4255 
Acceptance criteria NMT 2.0 NMT 2.0% NLT 2000 
S.No Parameter Name Dexketoprofen 
Drug in mg 
Dexketoprofen 
Drug in % 
Acceptance 
Criteria 
01 
Change in wavelength 231 
nm 
25.89 103.56 
 
02 
Change in wavelength 235 
nm 
25.88 103.52 
 
03 Robust flow rate 0.8mL 25.96 103.84  
04 Robust flow rate 1.2mL 26.20 104.80  
05 
Robust mobile phase  
composition + 5 % 
25.80 103.20 
 
06 
Robust mobile phase  
composition  - 5 % 
26.08 104.32 
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Report:  
System suitability result passes in all the deliberately changed methods and the results 
obtained for all deliberately changed methods are found within the acceptance criteria.  
It is concluded that the deliberately changed assay methods results are remains 
unaffected in small variations which confirmed that all the methods are proficient to 
estimate Dexketoprofen Tablets. 
VIII) STABILITY OF ANALYTICAL SOLUTIONS: 
Solutions to be used in the analytical method should be analyzed for the study of their 
stability. This study should be performed by injecting standard solution and sample 
solution at probable time points, and minimum not less than 24 hours shall be studied. 
Solution Stability for Dexketoprofen Standard Solution 
S. No. 
Time point 
Standard 
solution 
area 
Results obtained 
Cumulative % 
RSD 
Tailing 
factor 
obtained 
Theoretical 
plate 
obtained 
  01 0
th
 hour 632676886 0.000 1.540 5266 
  02 1st hour 633114563 0.049 1.520 5319 
  03 2
nd
 hour 633733706 0.084 1.540 5318 
  04 3
rd
 hour 633355442 0.070 1.530 5337 
  05 4
th
 hour 633537559 0.065 1.520 5342 
  06 5
th
 hour 633045093 0.060 1.540 5303 
  07 6th hour 634033916 0.072 1.480 5316 
08 7
th
 hour 634046484 0.077 1.520 5292 
09 8
th
 hour 633745916 0.074 1.510 5300 
10 9
th
 hour 633765012 0.071 1.510 5304 
11 10th hour 633514978 0.067 1.540 5295 
12 11
th
 hour 633405833 0.064 1.520 5309 
13 12
th
 hour 633968097 0.065 1.490 5359 
14 13
th
 hour 633831257 0.064 1.480 5379 
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                              Table No. 28 : Solution Stability for Dexketoprofen  Standard 
Solution Stability for Dexketoprofen Standard Solution 
15 14th hour 633438369 0.062 1.470 5421 
16 15
th
 hour 633248917 0.061 1.530 5356 
17 16
th
 hour 633504053 0.059 1.450 5385 
18 17
th
 hour 633043809 0.060 1.490 5395 
19 18th hour 632865627 0.062 1.480 5365 
20 19
th
 hour 632920245 0.064 1.470 5279 
21 20
th
 hour 632590841 0.069 1.440 5379 
22 21
th
 hour 632795102 0.070 1.410 5309 
23 22
th
 hour 632594622 0.073 1.430 5303 
24 23th hour 632740294 0.074 1.440 5263 
25 24
th
 hour 632775828 0.074 1.390 5302 
Limit NMT 2.0 % NMT 2.0 NLT 2000 
S. No. 
 Time point 
Sample 
solution 
area 
Results obtained 
Cumulative % 
RSD 
Tailing 
factor 
obtained 
Theoretical 
plate 
obtained 
  01  0th hour 676698822 0.000 1.590 5230 
  02  1
st
 hour 677464246 0.080 1.540 5299 
  03     2
nd
 hour 677172436 0.057 1.580 5266 
  04      3
rd
 hour 677651361 0.061 1.510 5380 
  05 4th hour 677569280 0.057 1.570 5310 
  06   5
th
 hour 677809028 0.059 1.550 5286 
  07 6
th
 hour 678750466 0.093 1.520 5285 
08 7
th
 hour 678860187 0.109 1.510 5281 
09 8
th
 hour 678715469 0.112 1.550 5238 
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                               Table No.29 : Solution Stability for Dexketoprofen  Sample 
Conclusion for stability of analytical solutions: 
System suitability result passes and the results obtained for stability of standard solution and 
sample solution are found within the acceptance criteria for the minimum period of 24 hours 
study. Hence, it is concluded that the standard solution and sample solution as mentioned in 
the assay method are capable to inject into the chromatography within 24 hours from the 
time of preparations.  
 
10 9th hour 678299846 0.108 1.530 5270 
11 10
th
 hour 678003409 0.102 1.520 5305 
12 11
th
 hour 679195506 0.112 1.500 5304 
13 12
th
 hour 678573067 0.110 1.500 5327 
14 13th hour 679411801 0.118 1.500 5362 
15 14
th
 hour 679983253 0.133 1.520 5394 
16 15
th
 hour 679306507 0.134 1.510 5367 
17 16
th
 hour 679743431 0.139 1.480 5520 
18 17
th
 hour 678884006 0.136 1.490 5359 
19 18th hour 678619091 0.132 1.490 5353 
20 19
th
 hour 680201604 0.141 1.460 5237 
21 20
th
 hour 679636180 0.142 1.460 5303 
22 21
th
 hour 679752492 0.143 1.470 5284 
23 22
th
 hour 679231196 0.141 1.470 5267 
24 23th hour 679794857 0.142 1.400 5219 
25 24
th
 hour 679765426 0.142 1.390 5262 
Limit NMT 2.0% NMT 2.0 NLT 2000 
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RESULT AND DISCUSSION   
  The objective of the proposed work was method development for the in 
estimation of Dexketoprofen in tablets by RP-HPLC and to validate the developed 
method according to USP and ICH guidelines and applying the same for use in the 
quality control samples in pharmaceutical industry.  
  As there is no official method for the estimation of Dexketoprofen , so we tried 
to develop a method by which we can quantify the amount of drug present in the given 
sample.  
  In RP-HPLC method, the conditions were optimized, to estimation of 
dexketoprofen. Initially, various mobile phase compositions were tried, to got better 
elution of drug. Mobile phase and flow rate selection was based on peak parameters 
(height, tailing, theoretical plates, capacity or symmetry factor), run time and 
resolution. The system with buffer and Methanol: Water (2:48:50) at gradient flow rate 
of 1.5ml min
 
was found to be quite robust.  
  The optimum wavelength for detection was 260 nm at which better detector 
response for the drug was obtained. The average retention times for Dexketoprofen was 
found to be 4.5 min, respectively. According to United States Pharmacopeia, system 
suitability tests are an integral part of chromatographic method. They are used to verify 
the reproducibility of the chromatographic system. To ascertain its effectiveness, 
system suitability tests were carried out on freshly prepared stock solutions. The 
calibration was linear in various concentration range with correlation.  
  The low values of RSD indicate that the method was precise and accurate. The 
mean recoveries were found in the range of 98 – 102 %. System precision is evaluated 
by injecting 10 injections of standard solution and low value of % RSD shows that 
system is precise. Precision for method is evaluated by analyzing a sample of 
homogenous batch six times and the low % RSD value shows the method is precise  
   Method robustness was evaluated by alteration of flow rate (±10%), Mobile 
phase organic content (±5°C), Wavelength (±2 nm) and it was found robust as % RSD 
was below 2.0%.  
  Ruggedness of the proposed method was determined by analysis of aliquots 
from homogeneous slot in different laboratories, by different analysts, different column, 
different system using similar environmental conditions, the % R.S.D. reported was 
found to be less than 2 %. The proposed method was validated in accordance with ICH 
parameters and the applied for analysis of the same in marketed formulations.  
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  Both sample solution and standard solution are stable at 25°C for24 hrs. as the 
% difference in the area was found to be less than 2.0%.   
  Finally, it can be concluded that the assay values of formulation were the same 
as mentioned in the label claim with the RSD of < 1.0%. The proposed method was 
found to be accurate, precise, reproducible and stable, and can be successfully applied 
for the routine analysis of the drug in tablet dosage forms. 
 
 
 
 
         
CONCLUSION  
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CONCLUSION  
 
       This assay method by HPLC is validated for statistical parameter and it is found 
that the analytical procedure for Dexketoprofen tablets 25 mg meets system suitability 
requirements and acceptance criteria for Specificity, Linearity, Precision, Accuracy, 
Robustness, Ruggedness parameters and Solution stability.  
 
      Solution stability study of the standard and sample preparations are found stable for   
a minimum of 24 hours.  There was no deviation obtained during this validation study. 
Hence, this In-House analytical method is recommended to carry out the assay analysis 
from now on for this indistinguishable formulation on Dexketoprofen Tablets 25 mg. 
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SUMMARY 
                                            
                                       Table. No. 30 :  Summary 
Validation 
Parameter 
Acceptance 
Criteria 
Results 
System 
Suitability 
The RSD Should 
be ≤2% for 5 
replicate 
injections for each 
peak 
0.172 
 
 
 
Specificity 
 
The peaks of 
diluents and 
placebo should 
not interfere with 
the main peaks 
 
 
The peaks of diluents and placebo did not 
interfering with the peaks of Dexketoprofen 
                                   Precision 
System 
Precision 
The %RSD of  5 
replicate 
injections should 
be≤2.0% 
0.071 
Method 
Precision 
The% RSD 
calculated on 6 
determinations of 
assay value 
should be ≤ 2% 
 
 
 
0.494 
 
 
 
Linearity 
 
The correlation 
coefficient should 
be ≥0.998 
 
 
0.99947 
 
 
Solution 
Stability 
 
RSD≤2.0% 
 
Standard and sample solutions are stable at 
25
0
c for 24hrs 
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